MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
F-box and WD-40 domain protein 7 (Fbw7) provides substrate specificity for the Skp1-Cullin1-F-box protein (SCF) ubiquitin ligase complex that targets multiple oncoproteins for degradation, including cyclin E, c-Myc, c-Jun, Notch, and mammalian target of rapamycin (mTOR). Fbw7 is a bona fide tumor suppressor, and loss-of-function mutations in FBXW7 have been identified in diverse human tumors. Although much is known about targets of the Fbw7 ubiquitin ligase pathway, relatively little is known about the regulation of Fbw7 expression. We identified a panel of candidate microRNA regulators of Fbw7 expression within a study of gene expression alterations in primary erythroblasts obtained from cyclin E(T74A T393A) knock-in mice, which have markedly dysregulated cyclin E expression. We found that overexpression of miR-223, in particular, significantly reduces FBXW7 mRNA levels, increases endogenous cyclin E protein and activity levels, and increases genomic instability. We next confirmed that miR-223 targets the FBXW7 3'-untranslated region. We then found that reduced miR-223 expression in primary mouse embryonic fibroblasts leads to increased Fbw7 expression and decreased cyclin E activity. Finally, we found that miR-223 expression is responsive to acute alterations in cyclin E regulation by the Fbw7 pathway. Together, our data indicate that miR-223 regulates Fbw7 expression and provide the first evidence that activity of the SCF(Fbw7) ubiquitin ligase can be modulated directly by the microRNA pathway.
Xu
Yanfei
Y
Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Sengupta
Tanushri
T
Kukreja
Lokesh
L
Minella
Alex C
AC
D020413:3' Untranslated Regions / Q000502:physiology*; D000818:Animals; D018797:Cell Cycle Proteins / Q000096:biosynthesis* / Q000235:genetics; D019927:Cyclin E / Q000235:genetics / Q000378:metabolism*; D044783:F-Box Proteins / Q000096:biosynthesis* / Q000235:genetics; D000073979:F-Box-WD Repeat-Containing Protein 7; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D020014:K562 Cells; D051379:Mice; D008822:Mice, Transgenic; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D016755:Proto-Oncogene Proteins c-jun / Q000235:genetics / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000378:metabolism; D051880:Receptors, Notch / Q000235:genetics / Q000378:metabolism; D044843:SKP Cullin F-Box Protein Ligases / Q000235:genetics / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000096:biosynthesis* / Q000235:genetics
D020413:3' Untranslated Regions; D018797:Cell Cycle Proteins; D019927:Cyclin E; D044783:F-Box Proteins; D000073979:F-Box-WD Repeat-Containing Protein 7; D035683:MicroRNAs; D016755:Proto-Oncogene Proteins c-jun; D016271:Proto-Oncogene Proteins c-myc; D051880:Receptors, Notch; D044843:SKP Cullin F-Box Protein Ligases; D058570:TOR Serine-Threonine Kinases; D044767:Ubiquitin-Protein Ligases; C513273:FBXW7 protein, human; C525067:MIR223, human; C544877:MIRN223 microRNA, mouse; C489427:MYC protein, human; C489428:Myc protein, mouse; C546842:MTOR protein, human
Nat Genet. 2005 May;37(5):495-500
15806104
EMBO J. 2007 Aug 8;26(15):3699-708
17627278
Curr Biol. 2002 Oct 29;12(21):1817-27
12419181
Cell. 2007 May 4;129(3):617-31
17482553
Genes Dev. 2009 Oct 15;23(20):2388-93
19833767
J Cell Biol. 2010 Feb 22;188(4):473-9
20176921
Cancer Sci. 2003 May;94(5):431-6
12824889
Gastroenterology. 2008 Jul;135(1):257-69
18555017
Cancer Res. 2010 May 1;70(9):3833-42
20406979
Cell. 2005 Dec 2;123(5):819-31
16325577
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4089-94
17360482
Genes Dev. 2008 Apr 15;22(8):986-91
18367647
J Biol Chem. 2001 Sep 21;276(38):35847-53
11461910
Mol Cell. 2003 Aug;12(2):381-92
14536078
Science. 2004 Feb 27;303(5662):1374-8
14739463
J Cell Mol Med. 2009 Nov-Dec;13(11-12):4551-9
19017354
Oncogene. 2006 Nov 23;25(55):7245-59
16751806
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9649-54
15980150
Nature. 2001 Sep 20;413(6853):316-22
11565034
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9085-90
15150404
J Biol Chem. 2007 Aug 10;282(32):23716-24
17569667
Cancer Res. 2004 Feb 1;64(3):795-800
14871801
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2889-94
18287052
Genes Dev. 2004 Mar 1;18(5):504-11
15014042
Urol Oncol. 2007 Sep-Oct;25(5):387-92
17826655
Blood. 2010 Mar 4;115(9):1768-78
20029046
J Biol Chem. 2004 Nov 26;279(48):50110-9
15364936
Mol Cell Biol. 1995 May;15(5):2612-24
7739542
Genes Dev. 1996 Aug 15;10(16):1979-90
8769642
Nature. 2001 Nov 29;414(6863):514-21
11734846
Nature. 1999 Sep 16;401(6750):297-300
10499591
Cancer Cell. 2005 Jul;8(1):35-47
16023597
EMBO J. 2004 May 19;23(10):2116-25
15103331
Mol Cancer. 2008 Apr 28;7:35
18442408
Cell Signal. 2008 May;20(5):862-71
18295447
Science. 2004 Jan 2;303(5654):83-6
14657504
Nature. 2004 Mar 4;428(6978):77-81
14999283
Cancer Res. 2008 Apr 15;68(8):2773-80
18413744
Nature. 2004 Dec 9;432(7018):775-9
15592418
Nat Rev Cancer. 2008 Feb;8(2):83-93
18094723
Nature. 2008 Feb 28;451(7182):1125-9
18278031
Cell. 2003 Dec 26;115(7):787-98
14697198
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3234-9
20133741
Cancer Cell. 2005 Jul;8(1):25-33
16023596
Science. 2008 Sep 12;321(5895):1499-502
18787170
Oncogene. 2007 Oct 18;26(48):6948-53
17486057
Haematologica. 2010 Jul;95(7):1114-21
20418243
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2183-8
20080666
Genes Dev. 2008 Jun 15;22(12):1677-89
18559482
Cancer Res. 2009 Jan 1;69(1):65-74
19117988
Mol Cell. 2007 Apr 13;26(1):131-43
17434132
Science. 2001 Oct 5;294(5540):173-7
11533444
J Cell Biol. 2008 Jun 16;181(6):913-20
18559665
Nature. 2007 Jun 21;447(7147):966-71
17515920
J Biol Chem. 2009 Mar 13;284(11):6605-9
19126550
EMBO J. 1996 Aug 15;15(16):4182-93
8861947
Curr Biol. 2004 Oct 26;14(20):1852-7
15498494